These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26575311)

  • 1. Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry.
    Wańha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Dola J; Morawiec B; Krzych Ł; Pawłowski T; Smolka G; Ochała A; Nowalany-Kozielska E; Tendera M; Wojakowski W
    Kardiol Pol; 2016; 74(6):561-9. PubMed ID: 26575311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences and bleeding complications after PCI on first and second generation DES.
    Wanha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Morawiec B; Kret M; Pawlowski T; Smolka G; Ochala A; Wojakowski W
    Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).
    Kawecki D; Morawiec B; Dola J; Wanha W; Smolka G; Pluta A; Marcinkiewicz K; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Arq Bras Cardiol; 2016 May; 106(5):373-81. PubMed ID: 27058257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry.
    Wańha W; Kawecki D; Roleder T; Morawiec B; Gładysz S; Kowalówka A; Jadczyk T; Adamus B; Pawłowski T; Smolka G; Kaźmierski M; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Aging Clin Exp Res; 2017 Oct; 29(5):885-893. PubMed ID: 27832467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents.
    Wańha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Morawiec B; Dola J; Gładysz S; Pawłowski T; Smolka G; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Cardiorenal Med; 2017 Feb; 7(2):85-95. PubMed ID: 28611782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).
    Kawecki D; Morawiec B; Dola J; Wańha W; Smolka G; Pluta A; Marcinkiewicz K; Ochała A; Nowalany-Kozielska E; Wojakowski W
    Med Sci Monit; 2015 Oct; 21():3261-9. PubMed ID: 26506478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study.
    Rodriguez AE; Santaera O; Larribau M; Sarmiento R; Haiek C; Del Pozo JF; Pavlovsky H; Rodriguez-Granillo AM;
    Minerva Cardioangiol; 2017 Feb; 65(1):81-90. PubMed ID: 27784884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.
    Rodriguez AE; Maree AO; Mieres J; Berrocal D; Grinfeld L; Fernandez-Pereira C; Curotto V; Rodriguez-Granillo A; O'Neill W; Palacios IF
    Eur Heart J; 2007 Sep; 28(17):2118-25. PubMed ID: 17656352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Pyxaras SA; Hunziker L; Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A; Naber CK
    EuroIntervention; 2016 Aug; 12(5):e623-31. PubMed ID: 27497362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second versus first generation DES in multiple vessel disease and unprotected left main stenosis: insights from ERACI IV Study.
    Rodriguez AE
    Minerva Cardioangiol; 2015 Aug; 63(4):317-27. PubMed ID: 25780954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.
    Sen H; Lam MK; Tandjung K; Löwik MM; van Houwelingen KG; Stoel MG; Louwerenburg HW; de Man FH; Linssen GC; Grandjean JG; Doggen CJ; von Birgelen C
    Int J Cardiol; 2014 Oct; 176(3):885-90. PubMed ID: 25168098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.